Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
Clinical trial NCT00390156 · COMPLETED
Trial details
- NCT number
- NCT00390156
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2011-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.